THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY PROGRAM ON THE PHARMACEUTICAL INDUSTRY (POPI) SYMPOSIUM COMMITTEE INVITES YOU TO ATTEND
THE 2005 FUTURE OF THE PHARMACEUTICAL INDUSTRY SYMPOSIUM
Addressing 21st Century GMPs:
Merging New and Existing Technology with Process Automation
to Deliver Science Based Manufacturing
DATE:
Wednesday, November 16, 2005
TIME:
8:00 A.M. - 5:30 P.M.
PLACE:
Massachusetts Institute of Technology (MIT)
Tang Center - Building E51
(Wong Auditorium)
Corner of Amherst Street & Wadsworth Street
Cambridge , MA 02139 -4307
The FDA's New Compliance Agenda calls for a comprehensive process and technology roadmap. Industry is calling for technologies like PAT, MES, ERP, Analytics, RFID and others, but where to begin and how to integrate new technologies is not always clear. Will technology create the ROI and efficiencies you need to compete?
MIT Program on the Pharmaceutical Industry (POPI) is pleased to join IBM, Rockwell Automation, The Consortium for the Advancement of Manufacturing of Pharmaceuticals (CAMP), MIT Engineering Systems Division (ESD), and the MIT Industrial Liaison Program (ILP) in sponsoring this symposium event. We invite you to join its panel of distinguished industry, technology and academic experts to understand which technology investments to make and the benefits and ROI these investments can realize. The transformation from inspection-based to science-based manufacturing will be a key discussion point for this event.
Please join the Massachusetts Institute of Technology, Program on the Pharmaceutical Industry (POPI), its sponsors and its panel of distinguished industry, technology and academic experts to understand which technology investments to make and the benefits and ROI these investments can realize.
The MIT Program on the Pharmaceutical Industry (POPI) is a unique university-industry-government collaboration based at MIT's Sloan School of Management. It was founded in 1991 to both perform multi-disciplinary research on the factors which drive, constrain and enhance the performance and competitiveness of the pharmaceutical/biotechnology industry, and to educate future scientific and management leaders for the industry and for those of the organizations which supply it, regulate it or use its products.
Among its research and educational accomplishments, POPI continues to contribute activities to areas including drug development, pharmaceutical manufacturing and the pharmaceutical marketplace. It has been supported by more than 30 faculties of MIT Schools of Engineering, Science and Humanities and Social Sciences, the MIT-Harvard Division of Health Sciences and Technology and the MIT Sloan School of Management.
Who Should Attend
The program has been designed for senior executives affiliated with Pharmaceutical Manufacturing, including: Chief Executive Officers, Presidents, Board Chairmen and Board Members, Executive Vice Presidents; Vice Presidents of Sales and Marketing, Manufacturing, Research and Development, Information Technology, Quality, Compliance, Finance and Operations; Corporate Counsel; Strategic Planners and other executives involved in the scientific, technical, quality or management issues related to Pharmaceutical Manufacturing.
Click here for the Conference Program
 Adobe Acrobat Reader
|
